Showing results (131-140 of 213) with videos related to

Sort By:
Pageof 22
Acta Otorrinolaringologica Espanola|August 31, 2001
[Hypopharynx and larynx basaloid squamous carcinoma: our experience with 6 cases]F Bracero, M J Gámiz, L Soldado, et al.
The Journal of Biological Chemistry|June 26, 2001
Solution structure and interaction with basic and acidic fibroblast growth factor of a 3-kDa human platelet factor-4 fragment with antiangiogenic activityR M Lozano, M Redondo-Horcajo, M A Jimenez, et al.
Biomed Research International|October 18, 2016
Use of Plant Extracts as an Effective Manner to Control <i>Clostridium perfringens</i> Induced Necrotic Enteritis in PoultryJ M Diaz Carrasco, L M Redondo, E A Redondo, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 14, 2012
Involvement of K-RAS mutations and amino acid substitutions in the survival of metastatic colorectal cancer patientsElisabeth Pérez-Ruiz, A Rueda, T Pereda, et al.
Annals of Hematology|December 25, 2014
Extranodal and nodal diffuse large B cell lymphoma of the head and neck: two different entities?L A Guardado Sánchez, A M Redondo, O Blanco Muñez, et al.
Gastroenterologia Y Hepatologia|July 9, 1999
[The effects of an oral calcium overload on the rat exocrine pancreas]M Redondo Valdeolmillos, M L del Olmo Martínez, A Almaraz Gómez, et al.
Vaccine|June 2, 1998
Effect of particulation on the immunogenic and protective properties of the recombinant Bm86 antigen expressed in Pichia pastorisJ C García-García, C Montero, M Rodríguez, et al.
Sleep Medicine|October 28, 2021
OSA patients not treated with PAP - Evolution over 5 years according to the Baveno classification and cardiovascular outcomesM Serino, C Cardoso, R J Carneiro, et al.
Cell Death and Differentiation|April 9, 2005
In vivo upregulation of CD95 and CD95L causes synergistic inhibition of angiogenesis by TSP1 peptide and metronomic doxorubicin treatmentA J Quesada, T Nelius, R Yap, et al.
British Journal of Pharmacology|July 23, 2013
Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitisC González-García, B Bravo, A Ballester, et al.
Pageof 22